Prostate cancer radiotherapy;Radioterapia raka gruczołu krokowego

Wspolczesna Onkologia

Volumn 15, Issue 5, 2011, Pages 317-329

  Kulik, Anna ^a   Da̧bkowski, Mateusz ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Brachytherapy; Prostate cancer; Radiotherapy

Indexed keywords

BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED RADIOTHERAPY; DISEASE SEVERITY; EXTERNAL BEAM RADIOTHERAPY; HEMATURIA; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERSTITIAL RADIATION; PAIN; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE; RADIATION INJURY; RADIATION RESPONSE; REVIEW; TELERADIOTHERAPY; TREATMENT CONTRAINDICATION; URINARY FREQUENCY; URINARY URGENCY; URINE INCONTINENCE;

EID: 82455181578     PISSN: 14282526     EISSN: None     Source Type: Journal    
DOI: 10.5114/wo.2011.25661     Document Type: Review

References (25)

1. Wojciechowska U, Didkowska J, Zatoński W. Nowotwory złośliwe w Polsce w 2008 roku. Wydawnictwo Centrum Onkologii - Instytut im. M. Skłodowskiej-Curie; Warszawa 2010.
2. Awan SB, Hussain M, Dini SA. Historical review of interstitial prostate brachytherapy. Iran J Radiat Res 2008; 5: 153-68.
3. Ray GR, Cassady JR, Bagshow MA. Definitive radiation therapy of carcinoma of the prostate. A report on 15 years of experience. Radiology 1973; 106: 407-18.
4. Consensus statement: the Management of Clinically Localized Prostate Cancer. National Institutes of Health Consensus Development Panel [no authors listed]. NCI Monogr 1988; 7: 3-6.
5. Akakura K, Suzuki H, Ichikawa T, et al. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months. Jpn J Clin Oncol 2006; 36: 789-93. (Pubitemid 47090734)
6. Paulson DF, Lin GH, Hinshaw W, Stephani S. Radical surgery versus radiotherapy for adenocarcinoma of the prostate. J Urol 1982; 128: 502-4. (Pubitemid 12037692)
7. Kupelian PA, Potters L, Khuntia D, et al. Radical prostatectomy, external beam radiotherapy < 72 Gy, external beam radiotherapy > or = 72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. Int J Radiat Oncol Biol Phys 2004; 58: 25-33. (Pubitemid 38010333)
8. Robinson JW, Moritz S, Fung T. Meta-analysis of rates of erectile function after treatment of localized prostate carcinoma. Int J Radiat Oncol Biol Phys 2002; 54: 1063-8. (Pubitemid 35292617)
9. Nilsson S, Norlén BJ, Widmark A. A systematic overview of radiation therapy effects in prostate cancer. Acta Oncol 2004; 43: 316-81. (Pubitemid 38887858)
10. Miszczyk L, Leszczyński W, Szczepanik K, et al. Comparison of two image guided radiation therapy (IGRT) methods used for prostate cancer patients - CBCT and 2D-2D kV. Przegl Lek 2008; 65: 315-20.
11. King CR, Brooks JD, Gill H, Presti JC Jr. Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer. Int J Radiat Oncol Biol Phys 2011 Feb 5.
12. Aznar MC, Petersen PM, Logadottir A, et al. Rational radiotherapy for prostate cancer in clinical practice. Radiother Oncol 2010; 97: 480-4.
13. Kanikowski M, Skowronek J, Milecki P, et al. Brachyterapia HDR raka gruczołu krokowego. Urol Pol 2007; 60: 5-11.
14. Kovacs G, Potter R, Loch T, et al. GEC/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localized prostate cancer. Radiother Oncol 2005; 74: 137-48. (Pubitemid 40331870)
15. Astrom I, Pedersen D, Mercke C, et al. Long-term outcome of high dose rate brachytherapy of localized prostate cancer. Radiother Oncol 2005; 74: 157-61. (Pubitemid 40331872)
16. Hoskin P. High dose rate brachytherapy for prostate cancer. Cancer/Radiotherapie 2008; 12: 512-4.
17. Akimoto T, Katoh H, Noda S. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Int J Radiat Oncol Biol Phys 2005; 63: 472-8. (Pubitemid 41317164)
18. Bachand F, Martin AG, Beaulieu I, et al. An eight-year experience of HDR brachytherapy boost for localized prostate cancer: biopsy and PSA outcome. Int J Radiat Oncol Biol Phys 2009; 73: 679-84.
19. Carpenter TJ, Forsythe K, Kao J, et al. Outcomes for patients with extraprostatic prostate cancer treated with trimodality therapy, including brachytherapy, external beam radiotherapy, and hormone therapy. Brachytherapy 2011; 10: 261-8.
20. Chen Y-C, Chuang C-K, Hsieh M-L, et al. High-dose-rate brachytherapy plus external beam radiotherapy for T1 to T3 prostate cancer: an experience in Taiwan. Urology 2007; 70: 101-5. (Pubitemid 47081086)
21. Demanes DJ, Rodriguez RR, Schour L, et al. High-Dose-Rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California Endocurietherapy's 10-year results. Int J Radiat Oncol Biol Phys 2005; 61: 1306-16. (Pubitemid 40470411)
22. Deutsch I, Zalefsky MJ, Zhang Z, et al. Comparison of PSA relapse-free survival In patients treated with ultra-dose IMRT versus combination HDR brachytherapy and IMRT. Brachytherapy 2010; 9: 313-8.
23. Galalae RM, Martinez AA, Mate T, et al. Long-term outcome by risk factors using conformal high dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer. Int J Radiat Oncol Biol Phys 2004; 58: 1048-55. (Pubitemid 38314785)
24. Ghadjar P, Rentsch CA, Isaak B, et al. Urethral toxicity vs. Cancer control-Lessons to be learned from high-dose rate brachytherapy combined with intensity-modulated radiation therapy in intermedia and high-risk prostate cancer. Brachytherapy 2011; 10: 286-94.
25. Hoskin P. High dose rate brachytherapy boost treatment in radical radiotherapy for prostate cancer. Radiother Oncol 2000; 57: 285-8.